Logo image
Back
Is HFE involved in increased hepcidin expression and hypoferremia in inflammation and anemia of chronic disease?
Journal article   Open access   Peer reviewed

Is HFE involved in increased hepcidin expression and hypoferremia in inflammation and anemia of chronic disease?

E.A. Milward, D. Trinder, C.E.J. Wilcox, R.S. Britton, G.A. Ramm and J.K. Olynyk
Hepatology, Vol.41(4), pp.936-938
2005
DOI: https://doi.org/10.1002/hep.20652
pdf
is_HFE_involved.pdfDownloadView
Published (Version of Record) Open Access
url
Link to Published Version *Subscription may be requiredView

Abstract

Inflammation influences iron balance in the whole organism. A common clinical manifestation of these changes is anemia of chronic disease (ACD; also called anemia of inflammation). Inflammation reduces duodenal iron absorption and increases macrophage iron retention, resulting in low serum iron concentrations (hyposideremia). Despite the protection hyposideremia provides against proliferating microorganisms, this “iron withholding” reduces the iron available to maturing red blood cells and eventually contributes to the development of anemia. Hepcidin antimicrobial peptide (Hamp) is a hepatic defensin-like peptide hormone that inhibits duodenal iron absorption and macrophage iron release. Hamp is part of the type II acute phase response and is thought to have a crucial regulatory role in sequestering iron in the context of ACD. Mice with deficiencies in the hemochromatosis gene product, Hfe, mounted a general inflammatory response after injection of lipopolysaccharide but lacked appropriate Hamp expression and did not develop hyposideremia. These data suggest a previously unidentified role for Hfe in innate immunity and ACD.

Details

Metrics

120 File views/ downloads
125 Record Views
Logo image